Literature DB >> 29464808

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.

Pietro Ameri1, Marco Canepa1, Markus S Anker2, Yury Belenkov3, Jutta Bergler-Klein4, Alain Cohen-Solal5, Dimitrios Farmakis6, Teresa López-Fernández7, Mitja Lainscak8, Radek Pudil9, Frank Ruschitska10, Petar Seferovic11, Gerasimos Filippatos6, Andrew Coats12, Thomas Suter13, Stephan Von Haehling14, Fortunato Ciardiello15, Rudolf A de Boer16, Alexander R Lyon17, Carlo G Tocchetti18.   

Abstract

Cancer and heart failure (HF) are common medical conditions with a steadily rising prevalence in industrialized countries, particularly in the elderly, and they both potentially carry a poor prognosis. A new diagnosis of malignancy in subjects with pre-existing HF is not infrequent, and challenges HF specialists as well as oncologists with complex questions relating to both HF and cancer management. An increased incidence of cancer in patients with established HF has also been suggested. This review paper summarizes the epidemiology and the prognostic implications of cancer occurrence in HF, the impact of pre-existing HF on cancer treatment decisions and the impact of cancer on HF therapeutic options, while providing some practical suggestions regarding patient care and highlighting gaps in knowledge.
© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.

Entities:  

Keywords:  Cancer; Co-morbidity; Heart failure; Prognosis; Therapy

Mesh:

Year:  2018        PMID: 29464808     DOI: 10.1002/ejhf.1165

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  36 in total

1.  Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure.

Authors:  Edoardo Bertero; Roberta Miceli; Alessandra Lorenzoni; Manrico Balbi; Giorgio Ghigliotti; Francesco Chiarella; Claudio Brunelli; Francesca Viazzi; Roberto Pontremoli; Marco Canepa; Pietro Ameri
Journal:  Intern Emerg Med       Date:  2019-03-05       Impact factor: 3.397

2.  Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.

Authors:  Melanie R Keats; Yunsong Cui; Vanessa DeClercq; Scott A Grandy; Ellen Sweeney; Trevor J B Dummer
Journal:  Support Care Cancer       Date:  2020-05-22       Impact factor: 3.603

3.  The Function, Role and Process of DDX58 in Heart Failure and Human Cancers.

Authors:  Ping Yu; Peng Liang; Shifeng Pang; Wenjian Yuan; Yuxiang Zhao; Qiaojuan Huang
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 4.  The cancer patient and cardiology.

Authors:  José Luis Zamorano; Christer Gottfridsson; Riccardo Asteggiano; Dan Atar; Lina Badimon; Jeroen J Bax; Daniela Cardinale; Antonella Cardone; Elizabeth A M Feijen; Péter Ferdinandy; Teresa López-Fernández; Chris P Gale; John H Maduro; Javid Moslehi; Torbjørn Omland; Juan Carlos Plana Gomez; Jessica Scott; Thomas M Suter; Giorgio Minotti
Journal:  Eur J Heart Fail       Date:  2020-10-02       Impact factor: 15.534

5.  The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative.

Authors:  Douglas J Leedy; Kerryn W Reding; Alexi L Vasbinder; Garnet L Anderson; Ana Barac; Jean Wactawski-Wende; Aladdin H Shadyab; Charles B Eaton; Wayne C Levy; LiHong Qi; Richard K Cheng
Journal:  Eur J Heart Fail       Date:  2021-06-06       Impact factor: 17.349

Review 6.  Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology.

Authors:  Edoardo Bertero; Pietro Ameri; Christoph Maack
Journal:  Card Fail Rev       Date:  2019-05-24

Review 7.  Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients.

Authors:  Alessandra Cuomo; Alessio Rodolico; Amalia Galdieri; Michele Russo; Giacomo Campi; Riccardo Franco; Dalila Bruno; Luisa Aran; Antonio Carannante; Umberto Attanasio; Carlo G Tocchetti; Gilda Varricchi; Valentina Mercurio
Journal:  Card Fail Rev       Date:  2019-05-24

Review 8.  The management of atrial fibrillation in heart failure: an expert panel consensus.

Authors:  Dimitrios Farmakis; Christina Chrysohoou; Gregory Giamouzis; George Giannakoulas; Michalis Hamilos; Katerina Naka; Stylianos Tzeis; Sotirios Xydonas; Apostolos Karavidas; John Parissis
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

Review 9.  RAAS: A Convergent Player in Ischemic Heart Failure and Cancer.

Authors:  Texali C Garcia-Garduño; Jorge R Padilla-Gutierrez; Diego Cambrón-Mora; Yeminia Valle
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

10.  Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.

Authors:  Xinyu Yang; Guoping Li; Manke Guan; Aneesh Bapat; Qianqian Dai; Changming Zhong; Tao Yang; Changyong Luo; Na An; Wenjing Liu; Fan Yang; Haie Pan; Pengqian Wang; Yonghong Gao; Ye Gong; Saumya Das; Hongcai Shang; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.